Patents by Inventor So Hee HYUN

So Hee HYUN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Composition and method for treating muscle cramps containing choline alfoscerate as active ingredient
    Patent number: 11612611
    Abstract: Choline alfoscerate is a drug used to improve cerebrovascular diseases and brain metabolism. It is a drug with proven safety, which has no effect on the kidney and liver and with no severe side effect reported. When administered to a patient with muscle cramps, it can significantly reduce pain and the occurrence of muscle cramps. Accordingly, it may be used as an active ingredient in a pharmaceutical composition for treating or preventing muscle cramps and a health functional food composition for improving muscle cramps and may also be used for a method for treating muscle cramps by administering choline alfoscerate. In addition, choline alfoscerate may also be used to prepare a medication for treating muscle cramps.
    Type: Grant
    Filed: November 26, 2018
    Date of Patent: March 28, 2023
    Assignee: HUB WASHINGTON INC.
    Inventors: Kweon Haeng Lee, Jun-Ho Yeo, Young Lim, Kunik Lee, So Hee Hyun
  • Composition and method for treating, relieving or preventing neuropathic pain, containing choline alfoscerate as active ingredient
    Patent number: 11311561
    Abstract: Choline alfoscerate is useful for treating cognitive dysfunction associated with cerebrovascular diseases and degenerative brain diseases. It is a drug with proven safety, which has no effect on the kidney and liver and with no severe side effect reported. When administered to a patient with neuropathic pain, it can significantly reduce the pain intensity and the occurrence of neuropathic pain. Accordingly, it may be used as an active ingredient in a pharmaceutical composition for treating or preventing neuropathic pain and a health functional food composition for improving neuropathic pain and may also be used for a method for treating neuropathic pain by administering choline alfoscerate. In addition, choline alfoscerate may also be used to prepare a medication for treating neuropathic pain.
    Type: Grant
    Filed: December 10, 2018
    Date of Patent: April 26, 2022
    Assignee: Hub Washington Inc.
    Inventors: Kweon Haeng Lee, Jun-Ho Yeo, Young Lim, Kunik Lee, So Hee Hyun
  • COMPOSITION AND METHOD FOR TREATING, RELIEVING OR PREVENTING MUSCLE CRAMPS, CONTAINING CHOLINE ALFOSCERATE AS ACTIVE INGREDIENT
    Publication number: 20210169906
    Abstract: Choline alfoscerate is a drug used to improve cerebrovascular diseases and brain metabolism. It is a drug with proven safety, which has no effect on the kidney and liver and with no severe side effect reported. When administered to a patient with muscle cramps, it can significantly reduce pain and the occurrence of muscle cramps. Accordingly, it may be used as an active ingredient in a pharmaceutical composition for treating or preventing muscle cramps and a health functional food composition for improving muscle cramps and may also be used for a method for treating muscle cramps by administering choline alfoscerate. In addition, choline alfoscerate may also be used to prepare a medication for treating muscle cramps.
    Type: Application
    Filed: November 26, 2018
    Publication date: June 10, 2021
    Applicant: NANOSTEM CO., LTD.
    Inventors: Kweon Haeng LEE, Jun-Ho YEO, Young LIM, Kunik LEE, So Hee HYUN
  • COMPOSITION AND METHOD FOR TREATING, RELIEVING OR PREVENTING NEUROPATHIC PAIN, CONTAINING CHOLINE ALFOSCERATE AS ACTIVE INGREDIENT
    Publication number: 20200338099
    Abstract: Choline alfoscerate is useful for treating cognitive dysfunction associated with cerebrovascular diseases and degenerative brain diseases. It is a drug with proven safety, which has no effect on the kidney and liver and with no severe side effect reported. When administered to a patient with neuropathic pain, it can significantly reduce the pain intensity and the occurrence of neuropathic pain. Accordingly, it may be used as an active ingredient in a pharmaceutical composition for treating or preventing neuropathic pain and a health functional food composition for improving neuropathic pain and may also be used for a method for treating neuropathic pain by administering choline alfoscerate. In addition, choline alfoscerate may also be used to prepare a medication for treating neuropathic pain.
    Type: Application
    Filed: December 10, 2018
    Publication date: October 29, 2020
    Applicant: NANOSTEM CO., LTD.
    Inventors: Kweon Haeng LEE, Jun-Ho YEO, Young LIM, Kunik LEE, So Hee HYUN